About DNAFit
DNAFit is a company based in London (United Kingdom) founded in 2013 was acquired by Prenetics in April 2018. The company has 313 employees as of January 31, 2021. DNAFit offers products and services including Premium DNA Test, Healthy Body Reports, Family Planning Screening, and Skin and Wellness Reports. DNAFit operates in a competitive market with competitors including Segterra (InsideTracker), InformedDNA, MyOme, GenoPalate and Dante Labs, among others.
- Headquarter London, United Kingdom
- Employees 313 as on 31 Jan, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prenetics Emea Limited
- Date of Incorporation 07 Jan, 2014
- Jurisdiction BOLTON, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of DNAFit
DNAFit offers a comprehensive portfolio of products and services, including Premium DNA Test, Healthy Body Reports, Family Planning Screening, and Skin and Wellness Reports.
Comprehensive analysis of DNA for health risks and personalized recommendations.
Genetic reports on diet, fitness, and nutrition tailored to individual DNA.
Tests for hereditary conditions to inform family health decisions.
DNA-based insights for skincare and stress management strategies.
Funding Insights of DNAFit
Detailed funding history for DNAFit
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in DNAFit
DNAFit has secured backing from 1 investor. Prominent investors backing the company include Prenetics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health risks are identified through online genetic and diagnostic testing.
|
Locked | Locked | Locked |
Investor details for DNAFit
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DNAFit
Investment portfolio details for DNAFit
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DNAFit
Detailed financials for DNAFit
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dnafit Comparisons
Peer comparison for DNAFit
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DNAFit
DNAFit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Segterra (InsideTracker), InformedDNA, MyOme, GenoPalate and Dante Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood samples are analyzed for personalized health and wellness recommendations.
|
|
| Locked | Locked | Locked |
Network of genetics experts provided to assist patients and providers.
|
|
| Locked | Locked | Locked |
Provider of a platform for gene analysis to determine genetic diseases and drug response
|
|
| Locked | Locked | Locked |
Personalized diet plans are offered based on genetic analysis.
|
|
| Locked | Locked | Locked |
Whole-genome sequencing analysis is offered for health and wellness insights.
|
|
| Locked | Locked | Locked |
Online platform offering DNA-based recommendations for health and wellness
|
Detailed competitors of DNAFit
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dnafit
Complete news archive for DNAFit
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DNAFit
DNAFit was founded in 2013.
DNAFit is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
As of Jan 31, 2021, the latest employee count at DNAFit is 313.
DNAFit was founded in 2013 and is headquartered in London, United Kingdom. Operations focus on the health and wellness sector, where personalized recommendations for fitness and diet are generated through DNA analysis. Users purchase a saliva sample kit online, submit samples for testing, and receive tailored advice on goals such as weight loss, muscle building, healthy eating, sports performance enhancement, and overall wellness.
DNAFit's top competitors include Segterra (InsideTracker), Dante Labs and GenoPalate.
DNAFit offers Premium DNA Test, Healthy Body Reports, Family Planning Screening, and Skin and Wellness Reports.
DNAFit has 1 investor. Key investors include Prenetics.